Russell W. Madison

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Andrea Necchi, Andrea Anichini, Daniele Raggi et al. · Journal of Clinical Oncology · 2018 · 712 citations

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan et al. · Nature · 2021 · 416 citations · Full text

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2019 · 313 citations

Urology, Genitourinary Cancer, Muscle-invasive Bladder Carcinoma +7

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Jonathan W. Riess, David R. Gandara, Garrett M. Frampton et al. · Journal of Thoracic Oncology · 2018 · 224 citations

Functional Genomics, Engineering, Comprehensive Genomic Profiling +7

Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study

Zachery R. Reichert, Todd M. Morgan, Gerald Li et al. · Annals of Oncology · 2022 · 188 citations · Full text